@article{cceb5196c1074031a7b7c36e855ac8c5,
title = "Development, implementation, and outcomes of a simulation-based medical education (SBME) prostate brachytherapy workshop for radiation oncology residents",
abstract = "Purpose: Despite a preponderance of data demonstrating strong clinical outcomes and cost-effectiveness, prostate brachytherapy use and competency continue to decline. Enhanced resident education may help reverse this trend. We therefore developed and implemented a simulation-based medical education course for low-dose-rate prostate brachytherapy (LDR-PB). Materials and Methods: A 1-week LDR-PB course comprised four 1-h lectures on clinical outcomes, physics, radiobiology, and anatomy/contouring, followed by a 4.5-h simulation session on ultrasound-guided prostate phantom implantation, was developed for radiation oncology residents at an academic institution. A 10-statement Likert-scale survey and 20-question multiple-choice test were administered 1 week before and 4 weeks after the course. Results: Precourse and postcourse instruments were completed by 24 and 20 residents, respectively. The median number of prior LDR-PB cases after at least one genitourinary rotation was 10.5 (range 5–20). Overall mean test scores were significantly improved (55% before the course vs 68% after the course; p = 0.010). Mean Likert scores significantly increased on nine of 10 survey statements and were significantly increased overall (2.4 before the course vs 3.3 after the course, p < 0.001). When asked about interest in performing brachytherapy after residency, 37.5% of residents “agreed” or “strongly agreed” before the course vs 50% after the course (p = 0.41). Those with higher postresidency brachytherapy interest (scores of 4–5 vs 1–3) had significantly more LDR-PB cases (11.2 vs 5.3 cases; p = 0.005). Conclusions: A 1-week simulation-based medical education course for LDR-PB can improve didactic performance and self-reported technical competence/confidence, and may increase overall enthusiasm for brachytherapy. Future studies at our institution will incorporate evaluation of implant quality and assessment of procedural competence into this framework. Residency programs should dedicate resources to this essential component of radiation oncology.",
keywords = "Brachytherapy, Prostate, Radiation oncology residency, SBME, Simulation",
author = "Shane Mesko and Chapman, {Bhavana V.} and Chad Tang and Kudchadker, {Rajat J.} and Bruno, {Teresa L.} and Jeremiah Sanders and Prajnan Das and Pinnix, {Chelsea C.} and Thaker, {Nikhil G.} and Frank, {Steven J.}",
note = "Funding Information: Disclosures: Dr. Das reports personal fees from Adlai Nortye and personal fees from MD Anderson Cancer Center Madrid Spain, outside the submitted work. Dr. Mesko reports consulting fees from Oscar Health, outside the submitted work. Dr. Tang reports personal fees from Reflexion, personal fees from AstraZeneca and personal fees from Wolter Kluwer, outside the submitted work. In addition, Dr. Tang has a patent U.S. Patent #9,175,079 licensed to The Board of Trustees of the Leland Stanford Junior University. Dr. Thaker reports consulting fees from McKesson Specialty Health. Dr. Frank reports personal fees from Varian, grants and personal fees from C4 Imaging, grants from Eli Lilly, grants from Elekta, grants and personal fees from Hitachi, other from Breakthrough Chronic Care, personal fees from Boston Scientific, personal fees from National Comprehensive Cancer Center (NCCN), outside the submitted work. All other others have no disclosures to report. Funding Information: Supported in part by Cancer Center Support (Core) Grant P30 CA016672 from the National Cancer Institute, National Institutes of Health, to The University of Texas MD Anderson Cancer Center. Funding Information: Supported in part by Cancer Center Support (Core) Grant P30 CA016672 from the National Cancer Institute, National Institutes of Health, to The University of Texas, MD Anderson Cancer Center. Funding Information: They authors would like to thank the following vendors for their assistance with this simulation workshop:, Ultrasound units: Sonoscape (China); Best Medical Int. (Springfield, VA); BK Medical (Peabody, MA);, Dummy Seed/Spacer Kits: Theragenics Corporation (Buford, GA); Isoaid (Port Richey, FL);, Treatment Planning Software: MIM Software (Beachwood, OH);, Tables & Associated Interfaces: American Brachytherapy Society. Supported in part by Cancer Center Support (Core) Grant P30 CA016672 from the National Cancer Institute, National Institutes of Health, to The University of Texas MD Anderson Cancer Center. Disclosures: Dr. Das reports personal fees from Adlai Nortye and personal fees from MD Anderson Cancer Center Madrid Spain, outside the submitted work. Dr. Mesko reports consulting fees from Oscar Health, outside the submitted work. Dr. Tang reports personal fees from Reflexion, personal fees from AstraZeneca and personal fees from Wolter Kluwer, outside the submitted work. In addition, Dr. Tang has a patent U.S. Patent #9,175,079 licensed to The Board of Trustees of the Leland Stanford Junior University. Dr. Thaker reports consulting fees from McKesson Specialty Health. Dr. Frank reports personal fees from Varian, grants and personal fees from C4 Imaging, grants from Eli Lilly, grants from Elekta, grants and personal fees from Hitachi, other from Breakthrough Chronic Care, personal fees from Boston Scientific, personal fees from National Comprehensive Cancer Center (NCCN), outside the submitted work. All other others have no disclosures to report. Supported in part by Cancer Center Support (Core) Grant P30 CA016672 from the National Cancer Institute, National Institutes of Health, to The University of Texas, MD Anderson Cancer Center. Publisher Copyright: {\textcopyright} 2020 American Brachytherapy Society",
year = "2020",
month = nov,
day = "1",
doi = "10.1016/j.brachy.2020.08.009",
language = "English (US)",
volume = "19",
pages = "738--745",
journal = "Brachytherapy",
issn = "1538-4721",
publisher = "Elsevier Inc.",
number = "6",
}